procainamide has been researched along with Myotonic Dystrophy in 15 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with myotonic dystrophy were allocated at random to treatment with disopyramide and procainamide in a cross-over trial." | 9.05 | A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy. ( Finlay, M, 1982) |
| "Ten patients with myotonic dystrophy were allocated at random to treatment with disopyramide and procainamide in a cross-over trial." | 5.05 | A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy. ( Finlay, M, 1982) |
| "Procainamide treatment was introduced and the digestive symptoms improved." | 1.35 | [Encopresis revealing myotonic dystrophy in 2 children]. ( Avez-Couturier, J; Cuisset, JM; Dolhem, P; Gottrand, F; Lamblin, MD; Michaud, L; Turck, D; Vallée, L, 2009) |
| " Patients with Thomsen's myotonia (9 cases) and with atrophic myotonia (7 cases) were treated by novocainamide with a daily dosage of 0." | 1.26 | [Treatment of patients with different forms of myotonia with diphenin and novocainamide]. ( Biriukov, VB, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avez-Couturier, J | 1 |
| Michaud, L | 1 |
| Cuisset, JM | 1 |
| Lamblin, MD | 1 |
| Dolhem, P | 1 |
| Turck, D | 1 |
| Vallée, L | 1 |
| Gottrand, F | 1 |
| KJELLIN, K | 1 |
| GESCHWIND, N | 1 |
| SIMPSON, JA | 1 |
| Finlay, M | 1 |
| Pelliccioni, G | 1 |
| Scarpino, O | 1 |
| Piloni, V | 1 |
| Coccagna, G | 1 |
| Mantovani, M | 1 |
| Parchi, C | 1 |
| Mironi, F | 1 |
| Lugaresi, E | 1 |
| Biriukov, VB | 1 |
| Griggs, RC | 1 |
| Davis, RJ | 1 |
| Anderson, DC | 1 |
| Dove, JT | 1 |
| Fitting, JW | 1 |
| Leuenberger, P | 1 |
| Ricker, K | 1 |
| Meinch, HM | 1 |
| Stumpf, H | 1 |
| Molina, J | 1 |
| Dubois, EL | 1 |
| Bilitch, M | 1 |
| Bland, SL | 1 |
| Friou, GJ | 1 |
| Anastassiades, TP | 1 |
| Miliiken, JA | 1 |
| Kuiper, DH | 1 |
| Negri, S | 1 |
| Prockop, LD | 1 |
1 trial available for procainamide and Myotonic Dystrophy
| Article | Year |
|---|---|
A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Disopyramide; Female; Humans; | 1982 |
14 other studies available for procainamide and Myotonic Dystrophy
| Article | Year |
|---|---|
[Encopresis revealing myotonic dystrophy in 2 children].
Topics: Adolescent; Anal Canal; Child; Child, Preschool; Encopresis; Humans; Male; Manometry; Myotonic Dystr | 2009 |
[Procaine amide in dystrophia myotonica].
Topics: Humans; Myotonic Dystrophy; Procainamide | 1957 |
Procaine amide in the treatment of myotonia.
Topics: Humans; Myotonia; Myotonic Dystrophy; Procainamide | 1955 |
Procainamide for faecal incontinence in myotonic dystrophy.
Topics: Adult; Fecal Incontinence; Humans; Male; Myotonic Dystrophy; Procainamide | 1999 |
Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.
Topics: Aminobutyrates; Disorders of Excessive Somnolence; Humans; Hypoventilation; Male; Middle Aged; Muscl | 1975 |
[Treatment of patients with different forms of myotonia with diphenin and novocainamide].
Topics: Humans; Myotonia Congenita; Myotonic Dystrophy; Phenytoin; Procainamide | 1976 |
Cardiac conduction in myotonic dystrophy.
Topics: Adolescent; Adult; Electrocardiography; Heart; Humans; Middle Aged; Myotonic Dystrophy; Phenytoin; P | 1975 |
Procainamide for dyspnea in myotonic dystrophy.
Topics: Diaphragm; Dyspnea; Female; Humans; Middle Aged; Muscle Relaxation; Myotonic Dystrophy; Procainamide | 1989 |
[Neurophysiological studies on the temporary paresis in myotonia congenita and dystrophia myotonica].
Topics: Action Potentials; Adult; Cell Membrane; Female; Guanidines; Humans; Magnesium; Male; Middle Aged; M | 1973 |
Procainamide-induced serologic changes in asymptomatic patients.
Topics: Aged; Antibodies, Antinuclear; Arrhythmias, Cardiac; Coronary Disease; Female; Heart Diseases; Human | 1969 |
Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.
Topics: Adult; Antibodies, Antinuclear; Blood Protein Electrophoresis; Female; Humans; Immune System Disease | 1972 |
Gastric bezoar in a patient with myotonic dystrophy. A review of the gastrointestinal complications of myotonic dystrophy.
Topics: Bezoars; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Methacholine Compound | 1971 |
An atypical case of Steinert's disease (myotonia dystrophica) in infancy.
Topics: Age Factors; Child; Creatine Kinase; Electroencephalography; Electromyography; Facial Muscles; Femal | 1971 |
Myotonia, procaine amide, and lupus-like syndrome.
Topics: Adult; Aged; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Myotonic Dystrophy; P | 1966 |